Consensus Becton, Dickinson and Company

Equities

BDX

US0758871091

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 01:30:02 06/06/2026 am IST			Pre-market 03:27:30 pm
151.16 ^USD	+1.07%		152.12	+0.64%

03/06	Becton Dickinson & Co Insider Sold Shares Worth $404,511, According to a Recent SEC Filing	MT
03/06	BDx secures data center power contract from Indonesia's PLN	RE

Evolution of the Average Target: Becton, Dickinson and Company

Evolution of the Target Price: Becton, Dickinson and Company

Changes in Analyst Recommendations: Becton, Dickinson and Company

3683.g6kOiGLl-nvo3eWTmfQOAihaIto66vOCrsiPZPzE0Bc.-_M5uyuxtUmwgoDXzc1UdGwSEpMJqZzTmoboHo--mWTn8WTPMISqFJ6tig~d46dfcde00a9d10300f5b8ee634f9b92

Analysts' recommendations: Becton, Dickinson and Company

27/05	Goldman Sachs Adjusts PT on Becton, Dickinson and Co. to $150 From $156, Maintains Neutral Rating	MT
08/05	Becton, Dickinson Building Growth After 'Clean' Fiscal Q2 Beat, RBC Says	MT
07/05	Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $190 From $180	MT
07/05	Stifel Nicolaus Adjusts Becton, Dickinson and Company Price Target to $175 From $215	MT
04/05	TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $163 From $189, Maintains Hold Rating	MT
04/05	U.S. research roundup - Alphabet, Colgate-Palmolive, Welltower	RE
17/04	Piper Sandler Adjusts Becton, Dickinson and Company PT to $159 From $170, Maintains Neutral Rating	MT
14/04	RBC Cuts Price Target on Becton, Dickinson to $175 From $195, Keeps Sector Perform Rating	MT
23/03	Argus Research Adjusts Becton, Dickinson and Company Price Target to $180 From $230, Maintains Buy Rating	MT
11/02	TD Cowen Adjusts Becton, Dickinson and Company PT to $189 From $183, Maintains Hold Rating	MT
11/02	Citigroup Adjusts Becton, Dickinson and Company PT to $198 From $232, Maintains Buy Rating	MT
10/02	Becton, Dickinson to See 'Transition Year' in 2026 as it Navigates Headwinds, RBC Says	MT
10/02	RBC Cuts Price Target on Becton, Dickinson to $172 From $210, Keeps Sector Perform Rating	MT
10/02	Piper Sandler Adjusts Becton, Dickinson and Company Price Target to $170 From $205, Maintains Neutral Rating	MT
10/02	JPMorgan Adjusts PT on Becton, Dickinson and Co. to $175 From $190, Maintains Neutral Rating	MT
10/02	Wells Fargo Adjusts PT on Becton, Dickinson and Co. to $157 From $184, Maintains Equalweight Rating	MT
10/02	Citigroup Adjusts PT on Becton, Dickinson and Co. to $232 From $233, Maintains Buy Rating	MT
10/02	Jefferies Adjusts PT on Becton, Dickinson and Co. to $190 From $220, Maintains Buy Rating	MT
03/02	Citigroup Resumes Becton, Dickinson at Buy With $233 Price Target	MT
03/02	Analyst recommendations: Exxon Mobil, Fair Isaac, Fedex, Mastercard, Palantir…
28/01	Piper Sandler Adjusts Becton, Dickinson and Company PT to $205 From $190, Maintains Neutral Rating	MT
17/12	RBC Adjusts Price Target on Becton, Dickinson to $210 From $202, Maintains Sector Perform Rating	MT
10/12	Jefferies Adjusts PT on Becton, Dickinson and Co. to $220 From $215, Maintains Buy Rating	MT
02/12	Agilent, Waters Face Diverging Outlooks on Growth and Integration Risks, Morgan Stanley Says	MT
02/12	Morgan Stanley Adjusts Price Target on Becton, Dickinson and Company to $210 From $197, Maintains Overweight Rating	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	BECTON, DICKINSON AND COMPANY					+19.89%
	ABBOTT LABORATORIES					+28.79%
	MEDTRONIC PLC					+20.7%
	HOYA CORPORATION					+14.33%
	CENCORA, INC.					+29.74%
	MEDLINE INC.					+52.18%
	DEXCOM, INC.					+13.92%
	WEST PHARMACEUTICAL SERVICES, INC.					+12.04%
	TERUMO CORPORATION					+29.93%
	STERIS PLC					+20.96%
	Average					+24.25%
	Weighted average by Cap.					+24.62%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

151.16USD

Average target price

181.23USD

Spread / Average Target

+19.89%

High Price Target

225.00USD

Spread / Highest target

+48.85%

Low Price Target

150.00USD

Spread / Lowest Target

-0.77%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Goldman Sachs
Evercore ISI
Stifel Nicolaus
TD Cowen
Piper Sandler
RBC Capital Markets
Argus
Citigroup
Jefferies & Co.
JPMorgan Chase
Wells Fargo Securities
Morgan Stanley
Barclays
Raymond James
BofA Securities
William Blair & Co.
DBS Bank
KeyBanc Capital Markets
Baird
UBS
SVB Leerink